Skip to main content
Back to Lightspeed Venture Partners

Lightspeed Venture Partners's Biotechnology Portfolio

Browse 24 Biotechnology companies funded by Lightspeed Venture Partners. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
24
Total Funding in Biotechnology
$3.8B

Biotechnology Portfolio Companies (24)

Export
BiopharmaBiotechnologyHealth CarePharmaceutical

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.

Boston, United States
September 2023
$100.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical

Seismic Therapeutic is a biotechnology company developing machine-learning technology for immunology drug development.

Watertown, United States
September 2024
$25.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth Care

3T Biosciences is an immunotherapy company that develops next-generation therapies for cancer and immune-mediated diseases.

Menlo Park, United States
August 2022
$40.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalTherapeutics

Abata Therapeutics develops regulatory T cell (Treg) therapies for treating autoimmune diseases including progressive multiple sclerosis.

Cambridge, United States
August 2024
Corporate Round

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceOncologyPrecision Medicine

Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.

Boston, United States
July 2024
$150.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareWellness

Ancora Biotech is a privately held company supporting the clinical development of three multi-specific antibodies.

Palo Alto, United States
June 2022
$60.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareOncologyTherapeutics

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

Boston, United States
May 2026
$25.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareMedicalNeuroscienceRobotics

Neuralink is a neurotechnology company that focuses on developing brain-computer interfaces designed to treat neurological disorders.

Fremont, United States
May 2026
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical

Ultima Genomics is a developer of a low-cost sequencing platform.

Newark, United States
May 2022
$600.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareHealth Diagnostics

Karius delivers genomic insights into infectious diseases, helping clinicians make critical, life-saving treatment decisions.

Redwood City, United States
May 2024
$100.0M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyEdiscoveryHealth CareLife ScienceManufacturingTherapeutics

Antares is a biotechnology company focused on developing transformational,medicines targeting validated cancer and other serious diseases.

Boston, United States
May 2025
$177.0M
Series A

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareTherapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence.

South San Francisco, United States
April 2024
$1.0B
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedical

Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.

Newton, United States
March 2022
$82.5M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalNeuroscience

Science is a clinical-stage medical technology company that develops neuroengineering systems to address neurological and sensory disorders.

Alameda, United States
March 2026
$230.0M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareTherapeutics

Enlaza Therapeutics is a biotechnology research company.

La Jolla, United States
September 2025
$15.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

ImmunOs Therapeutics is a clinical-stage biotechnology company.

Schlieren, Switzerland
September 2024
$11.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.

London, United Kingdom
May 2024
$120.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife ScienceMedicalTherapeutics

Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.

Watertown, United States
January 2026
$125.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.

Lexington, United States
December 2025
$120.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareHealth Diagnostics

Personalis is a contract research organization and genome-scale diagnostics services company specializing in genome guided medicine.

Menlo Park, United States
December 2024
$50.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedicalTherapeutics

Protego Biopharma is a biotechnology company that develops therapeutics that aim to correct diseases caused by protein misfolding.

San Diego, United States
December 2025
$130.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsOncologyTherapeutics

Guardant Health is a precision oncology company that uses blood tests, data sets, and analytics to provide treatment to cancer patients.

Redwood City, United States
November 2025
$350.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Zag Bio is a biotechnology company that designs thymus-targeting bifunctional antibody medicines to treat and prevent autoimmune diseases.

Cambridge, United States
October 2025
$80.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalProduct Research

Alpha-9 Oncology is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.

Vancouver, Canada
October 2024
$175.0M
Series C

Founder Contacts

30,000+ verified contacts

Explore Lightspeed Venture Partners's Full Portfolio

View all companies funded by Lightspeed Venture Partners across every industry and funding stage.

View Full Lightspeed Venture Partners Portfolio